Ardent Health Partners, LLC (NYSE:ARDT – Free Report) – Equities researchers at KeyCorp dropped their FY2024 earnings per share estimates for shares of Ardent Health Partners in a research report issued to clients and investors on Monday, January 6th. KeyCorp analyst M. Gillmor now anticipates that the company will post earnings of $1.20 per share for the year, down from their prior estimate of $1.28. KeyCorp has a “Strong-Buy” rating on the stock. The consensus estimate for Ardent Health Partners’ current full-year earnings is $1.23 per share. KeyCorp also issued estimates for Ardent Health Partners’ Q4 2024 earnings at $0.44 EPS, Q1 2025 earnings at $0.55 EPS, Q2 2025 earnings at $0.54 EPS, Q3 2025 earnings at $0.43 EPS, Q4 2025 earnings at $0.54 EPS, FY2025 earnings at $2.05 EPS and FY2026 earnings at $2.27 EPS.
Several other research analysts have also recently weighed in on ARDT. Bank of America cut shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and cut their price target for the stock from $22.00 to $19.00 in a report on Wednesday, November 6th. Truist Financial reduced their target price on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a report on Monday. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $20.00 price target on shares of Ardent Health Partners in a report on Tuesday, December 17th. Stephens restated an “overweight” rating and issued a $24.00 price objective on shares of Ardent Health Partners in a research note on Thursday, September 19th. Finally, Leerink Partners lifted their target price on Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 12th. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Ardent Health Partners has an average rating of “Buy” and a consensus target price of $22.00.
Ardent Health Partners Stock Up 0.3 %
ARDT opened at $16.41 on Thursday. Ardent Health Partners has a 1 year low of $14.57 and a 1 year high of $20.72. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The business’s fifty day moving average price is $16.62.
Hedge Funds Weigh In On Ardent Health Partners
Several hedge funds have recently made changes to their positions in ARDT. Seven Grand Managers LLC bought a new stake in Ardent Health Partners during the third quarter valued at $2,298,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Ardent Health Partners during the 3rd quarter valued at about $13,119,000. Financial Management Professionals Inc. purchased a new position in shares of Ardent Health Partners during the third quarter worth about $50,000. Charles Schwab Investment Management Inc. purchased a new position in shares of Ardent Health Partners during the third quarter worth about $526,000. Finally, BNP Paribas Financial Markets bought a new position in shares of Ardent Health Partners in the third quarter worth approximately $42,000.
Ardent Health Partners Company Profile
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Recommended Stories
- Five stocks we like better than Ardent Health Partners
- 3 Best Fintech Stocks for a Portfolio Boost
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- How to Use the MarketBeat Stock Screener
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Why Are Stock Sectors Important to Successful Investing?
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.